The TIF approach treats the root cause of GERD; an endoscope is used to place the EsophyX device into the esophagus to prevent stomach acid from damaging the lining.
Clinical studies showed 81 to 90 percent of patients were relieved of symptoms for up to two years.
More Articles on Gastroenterology:
Heat Waves Spark Bowel Inflammation, Study Says
Illinois Gastroenterology Group of Elgin Acquires 4-Physician Practice
Medigus Appoints Christopher Rowland to CEO
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.